Fellowship-trained Head and Neck Surgical Oncologist and Microvascular Reconstructive Surgeon Joins Karmanos in Detroit and Flint

News provided by

Sep 23, 2024, 07:15 ET

The head and neck surgeon specialist is now seeing new patients

DETROIT, Sept. 23, 2024 /PRNewswire/ -- The Barbara Ann Karmanos Cancer Institute welcomes Nithin Peddireddy, M.D., a head and neck surgical oncologist specializing in benign and malignant head and neck neoplasms. These include mouth, jaw, and throat cancers, salivary gland masses, melanoma, and skin cancers of the face, neck and scalp. Dr. Peddireddy joins Karmanos's Head and Neck Oncology Multidisciplinary Team (MDT). He is accepting new patients at Karmanos Cancer Center in Detroit and Karmanos Cancer Institute at McLaren Flint. He joined Karmanos and McLaren Health Care on Aug. 19, 2024.

Nithin Peddireddy, M.D., joins the Barbara Ann Karmanos Cancer Institute in Detroit and the Karmanos Cancer Institute at McLaren Flint.

"It's such an honor to join an organization at the forefront of cancer treatment and development," said Dr. Peddireddy. "Being from the Greater Flint area, I am excited to be able to provide care for patients from my hometown and in Detroit. I'm ready to work with my patients and colleagues to provide the best care and options for removing head and neck masses and the reconstruction necessary afterward."

Dr. Peddireddy is an ear, nose and throat (ENT) physician with a subspecialty in advanced head and neck surgery, including thyroid and parathyroid surgery, and comprehensive reconstruction utilizing rotational flaps and microvascular surgery with free flaps. He'll work alongside medical and radiation oncologists, dental oncologists, endocrinologists, pathologists, radiologists, speech-swallow therapists, and other surgical oncologists to create individualized and thorough treatment plans for each of his patient cases.

"We continue to grow our expertise to offer patients across the state the best oncologic care," said George Yoo, M.D., FACS, chief medical officer at the Karmanos Cancer Hospital. "Dr. Peddireddy will work side by side with experienced oncologists and collaborate on complicated cases, where we work to give the patient the best outcome. Offering his services not only in Detroit but further into the Karmanos Cancer Network also gives more patients access to surgical treatment that may not be offered elsewhere."

"We are continuing our commitment to bring highly-trained oncology specialists to the Karmanos Cancer Institute at McLaren Flint so patients do not have to travel far to get the care they need," said Chris Candela, McLaren Flint President and CEO. "It has added significance to see someone like Dr. Peddireddy return to his hometown to be a valuable resource for the communities we serve."

Dr. Peddireddy finished his fellowship in head and neck surgical oncology and microvascular reconstruction at Case Western Reserve University in Cleveland, Ohio. He completed his residency in otolaryngology at the University of Michigan, received his doctorate of medicine at the University of Cincinnati, and completed his undergraduate education at the U-M. He has participated in grant-funded research, has clinical teaching experience, and has contributed to numerous published studies, articles, chapters, and abstracts. Dr. Peddireddy is also a member of the American Academy of Otolaryngology – Head and Neck Surgery.

View Dr. Peddireddy's physician profile here. To request an appointment, visit karmanos.org or call 1-800-KARMANOS.

About the Barbara Ann Karmanos Cancer Institute
Karmanos Cancer Institute is a leader in transformative cancer care, research and education through courage, commitment and compassion. The Karmanos vision is a world free of cancer. As part of McLaren Health Care, Karmanos is the largest provider of cancer care and research in Michigan. For more than 75 years, the administrative and research headquarters, along with the premier specialty cancer hospital, have been located in downtown Detroit. With 16 network sites, Karmanos delivers world-renowned care and access to clinical trials throughout Michigan and northern Ohio. The National Cancer Institute recognizes Karmanos as one of the best cancer centers in the nation with a comprehensive cancer center designation. Its academic partnership with the Wayne State University School of Medicine provides the framework for cancer research and education – defining new standards of care and improving survivorship. For more information, call 1-800-KARMANOS (800-527-6266) or visit www.karmanos.org. Follow Karmanos on Facebook, Twitter, LinkedIn and YouTube.

About McLaren Flint
McLaren Flint is a 378-bed tertiary teaching hospital in Flint, Michigan, offering a full range of comprehensive and advanced services for residents in greater Genesee County. McLaren Flint is affiliated with Michigan State University (MSU) College of Human Medicine in its medical residency programs, including family practice, internal medicine, general surgery, and orthopedic surgery. McLaren Flint also maintains Fellowship programs in vascular surgery, health psychology, cardiology, and pulmonary and critical care in partnership with MSU. McLaren Flint is certified as a BCBSM Blue Distinction Center+ for Bariatric Surgery and Spine Surgery and has earned the Advanced Comprehensive Stroke Center Designation by the Joint Commission and 2024 Get with the Guidelines Gold Plus Award for Stroke Care from the American Heart Association. McLaren Flint is further designated a Breast Imaging Center of Excellence by the American College of Radiology and holds Laboratory Accreditation from the American College of Pathologists. The Karmanos Cancer Institute at McLaren Flint is accredited by the American College of Radiology Radiation Oncology Practice and Michigan Radiation Oncology Quality Consortium (MROQC) 2021 Gold. Learn more at mclaren.org/flint.

About McLaren Health Care
McLaren Health Care, headquartered in Grand Blanc, Michigan, is a $6.6 billion, fully integrated health care delivery system committed to quality, evidence-based patient care and cost efficiency. The McLaren system includes 13 hospitals in Michigan, ambulatory surgery centers, imaging centers, a 640-member employed primary and specialty care physician network, commercial and Medicaid HMOs covering more than 732,838 lives in Michigan and Indiana, home health, infusion and hospice providers, pharmacy services, a clinical laboratory network and a wholly owned medical malpractice insurance company. McLaren operates Michigan's largest network of cancer centers and providers, anchored by the Karmanos Cancer Institute, a National Cancer Institute-designated comprehensive cancer centers. McLaren has 28,000 full-, part-time and contracted employees and more than 113,000 network providers throughout Michigan, Indiana and Ohio. Learn more at mclaren.org.